Assembling intelligence…
IGF::OT::IGF PRECLINICAL PREVENT CANCER PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERSPOP:9/22/2015 - 9/21/2018
| Company | Orders | Obligated | Latest order end |
|---|---|---|---|
| UNIVERSITY OF OKLAHOMA | 8 | $3.5M | 2021-07-07 |
| HHSN26100005 UNIVERSITY OF OKLAHOMA · National Institutes of Health | $834K | 2021-07-07 |
| HHSN26100008 UNIVERSITY OF OKLAHOMA · National Institutes of Health | $709K | 2021-06-14 |
| HHSN26100004 UNIVERSITY OF OKLAHOMA · National Institutes of Health | $599K | 2018-09-23 |
| HHSN26100003 UNIVERSITY OF OKLAHOMA · National Institutes of Health | $598K | 2018-09-23 |
| HHSN26100011 UNIVERSITY OF OKLAHOMA · National Institutes of Health | $521K | 2020-06-14 |